New neutral organic superbases with 1-azaazulene(s) as a molecular backbone are computationally designed, employing two basic substituents: dimethylaminocyclopropen-imines (CPI) and dimethylaminocyclopropeniminophosphazenes (CPI-P). Their proton affinities, gas basicities, and pK_a values in acetonitrile are obtained using density functional theory. Azaazulenes substituted with CPI have a computed PA in the gas phase ranging between 272.9 and 306.8 kcal mol^–1, with pK_a values in acetonitrile between 28.8 and 36 units. The substitution with the CPI-P group resulted in even stronger superbases, with a PA from 296.5 to 335.2 kcal mol^–1 and corresponding pK_a values from 33.9 to 50 units. This exceptionally strong thermodynamic basicity is accompanied by very high kinetic basicity as well; contrary to typical proton sponges, the release of a proton from the conjugate superbase does not demand high activation energy. Because synthetic routes for both substituents and azaazulenes are already known, newly designed superbases represent suitable targets for synthesis and application.

This study aims to test the inhibition potency of new thienobenzo/naphtho-triazoles toward cholinesterases, evaluate their inhibition selectivity, and interpret the obtained results by molecular modeling. The synthesis of 19 new thienobenzo/naphtho-triazoles by two different approaches resulted in a large group of molecules with different functionalities in the structure. As predicted, most prepared molecules show better inhibition of the enzyme butyrylcholinesterase (BChE), considering that the new molecules were designed according to the previous results. Interestingly, the binding affinity of BChE for even seven new compounds (1, 3, 4, 5, 6, 9, and 13) was similar to that reported for common cholinesterase inhibitors. According to computational study, the active thienobenzo- and naphtho-triazoles are accommodated by cholinesterases through H-bonds involving one of the triazole’s nitrogens, π-π stacking between the aromatic moieties of the ligand and aromatic residues of the active sites of cholinesterases, as well as π-alkyl interactions. For the future design of cholinesterase inhibitors and search for therapeutics for neurological disorders, compounds with a thienobenzo/naphtho-triazole skeleton should be considered.